Most US neurologists prescribing MS drugs have received pharma industry cash

Higher volume prescribers more likely to receive payments; and recipients more likely to prescribe that company’s drugs, especially if payments were larger, sustained, and recent Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to ...

2025-08-26T10:41:57+00:0026 August 2025|BMJ Open, Press release|

Companies may be misleading parents with “outrageous claims” about banking baby teeth

Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...

2025-08-26T10:24:27+00:0026 August 2025|Press release, The BMJ|

Youth vaping consistently linked to subsequent smoking, marijuana and alcohol use

As well as heightened risks of asthma, cough, injuries and mental ill health + possibly pneumonia, bronchitis, headaches, migraines, dizziness, low sperm count, poor oral health Vaping among teens and young people is consistently linked to subsequent smoking, marijuana and alcohol use, finds an overarching (umbrella) review of systematic reviews ...

2025-08-20T13:32:55+00:0020 August 2025|Press release, Tobacco Control|

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks ...

2025-08-20T12:17:44+00:0020 August 2025|Journal of Medical Ethics, Press release|

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

2025-08-15T14:49:00+00:0015 August 2025|Press release, The BMJ|

ADHD medication linked to reduced risk of suicide, drug abuse, transport accidents and criminal behaviour

Findings should help inform clinical practice and the debate on ADHD drug treatment Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviours, substance misuse, transport accidents, and criminality, finds a study published by The BMJ today. The researchers say this ...

2025-08-14T10:53:39+00:0014 August 2025|Press release, The BMJ|

Patients still view doctor’s white coat as symbol of professionalism and trust

But women doctors in this attire are often misidentified as nurses or medical assistants And preferences for doctors’ dress strongly influenced by clinical context/medical specialty  Patients are still more likely to trust doctors and consider them more professional when they wear white coats, although women doctors in this attire are ...

2025-08-14T10:48:51+00:0014 August 2025|BMJ Open, Press release|
Go to Top